Balneaves Lynda G, Bottorff Joan L, Hislop T Gregory, Herbert Carol
School of Nursing, University of British Columbia, Vancouver, Canada.
J Altern Complement Med. 2006 Jun;12(5):459-66. doi: 10.1089/acm.2006.12.459.
Previous research on complementary therapy use in populations of patients with breast cancer has failed to differentiate among the different types of therapies and utilization patterns, resulting in wide discrepancies in prevalence rates. The purpose of this study was to develop more refined and rigorous estimates of the prevalence of complementary therapy use in women with breast cancer and their level of commitment to complementary therapy. DESIGN AND SAMPLE/SETTING: Using a cross-sectional, retrospective survey design, a random sample of 334 women with breast cancer was drawn from a Canadian provincial cancer registry. Using an intensive therapy inventory, women were asked to indicate the therapies and practices they had used since cancer diagnosis, frequency of use, amount of effort associated with using each therapy, and financial cost of therapy use.
A substantial proportion of women with breast cancer were found to be using complementary therapies, with between 19.5% (most conservative estimate) and 79.9% (liberal estimate) of the women reporting the use of at least one complementary therapy following diagnosis. While the majority of therapies were used on a daily basis, a minimal amount of effort and finances was expended on complementary therapy use. Using two-way cluster analysis, two homogenous groups of complementary therapy users were identified based on level of commitment to complementary therapy use. Women with a low commitment to complementary therapy use comprised 73.9% of the sample and were more likely to be older and report less education than women with a moderate-to-high commitment to complementary therapy use.
The use of complementary therapies by women with breast cancer warrants more precise measurement to accurately capture the types of complementary therapies used and the level of commitment to complementary therapy use. The findings of this study point to the value of the concept of commitment in identifying individuals willing to commit substantial time, energy and financial resources to complementary therapy use.
先前针对乳腺癌患者群体使用补充疗法的研究未能区分不同类型的疗法及其使用模式,导致患病率差异很大。本研究的目的是更精确、严谨地估计乳腺癌女性使用补充疗法的患病率及其对补充疗法的投入程度。
设计与样本/背景:采用横断面回顾性调查设计,从加拿大一个省级癌症登记处随机抽取334名乳腺癌女性。使用一份密集疗法清单,要求女性指出自癌症诊断以来所使用的疗法和做法、使用频率、与每种疗法相关的精力投入以及疗法使用的财务成本。
发现相当一部分乳腺癌女性在使用补充疗法,19.5%(最保守估计)至79.9%(宽松估计)的女性报告在诊断后使用了至少一种补充疗法。虽然大多数疗法是每天使用,但在补充疗法使用上投入的精力和资金很少。通过双向聚类分析,根据对补充疗法使用的投入程度,确定了两组同质的补充疗法使用者。对补充疗法使用投入低的女性占样本的73.9%,与对补充疗法使用投入中等至高的女性相比,她们年龄更大,受教育程度更低。
乳腺癌女性使用补充疗法需要更精确的测量,以准确掌握所使用的补充疗法类型以及对补充疗法使用的投入程度。本研究结果表明,投入这一概念在识别愿意为使用补充疗法投入大量时间、精力和财力的个体方面具有价值。